These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1732439)

  • 1. Is [1-11C]putrescine useful as a brain tumor marker?
    Hiesiger EM; Fowler JS; Logan J; Brodie JD; MacGregor RR; Christman DR; Wolf AP
    J Nucl Med; 1992 Feb; 33(2):192-200. PubMed ID: 1732439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose transport across the blood-brain barrier in normal human subjects and patients with cerebral tumours studied using [11C]3-O-methyl-D-glucose and positron emission tomography.
    Brooks DJ; Beaney RP; Lammertsma AA; Herold S; Turton DR; Luthra SK; Frackowiak RS; Thomas DG; Marshall J; Jones T
    J Cereb Blood Flow Metab; 1986 Apr; 6(2):230-9. PubMed ID: 3007547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial PET studies of human cerebral malignancy with [1-11C]putrescine and [1-11C]2-deoxy-D-glucose.
    Hiesiger E; Fowler JS; Wolf AP; Logan J; Brodie JD; McPherson D; MacGregor RR; Christman DR; Volkow ND; Flamm E
    J Nucl Med; 1987 Aug; 28(8):1251-61. PubMed ID: 3039083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labeled putrescine as a probe in brain tumors.
    Volkow N; Goldman SS; Flamm ES; Cravioto H; Wolf AP; Brodie JD
    Science; 1983 Aug; 221(4611):673-5. PubMed ID: 6603020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbon-11-putrescine: back to the drawing board.
    Rottenberg DA
    J Nucl Med; 1992 Feb; 33(2):200-1. PubMed ID: 1732440
    [No Abstract]   [Full Text] [Related]  

  • 6. [Methyl-11C]thymidine positron emission tomography in tumoral and non-tumoral cerebral lesions.
    De Reuck J; Santens P; Goethals P; Strijckmans K; Lemahieu I; Boon P; Achten E; Lemmerling M; Vandekerckhove T; Caemaert J
    Acta Neurol Belg; 1999 Jun; 99(2):118-25. PubMed ID: 10427354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography study of human prostatic adenocarcinoma using carbon-11 putrescine.
    Wang GJ; Volkow ND; Wolf AP; Madajewicz S; Fowler JS; Schlyer DJ; MacGregor RR
    Nucl Med Biol; 1994 Jan; 21(1):77-82. PubMed ID: 9234267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies.
    Blacklock JB; Oldfield EH; Di Chiro G; Tran D; Theodore W; Wright DC; Larson SM
    J Neurosurg; 1987 Jul; 67(1):71-5. PubMed ID: 3496428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
    Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
    J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo metabolism of radiolabeled putrescine in gliomas: implications for positron emission tomography of brain tumors.
    Warnick RE; Pietronigro DD; McBride DQ; Flamm ES
    Neurosurgery; 1988 Oct; 23(4):464-9. PubMed ID: 3264387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of 11C-L- and D-methionine in brain tumors.
    Meyer GJ; Schober O; Hundeshagen H
    Eur J Nucl Med; 1985; 10(7-8):373-6. PubMed ID: 3874063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the accumulation kinetics of L-(methyl-11C)-methionine and D-(methyl-11C)-methionine in brain tumors studied with positron emission tomography.
    Bergström M; Lundqvist H; Ericson K; Lilja A; Johnström P; Långström B; von Holst H; Eriksson L; Blomqvist G
    Acta Radiol; 1987; 28(3):225-9. PubMed ID: 2958026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy.
    Terakawa Y; Tsuyuguchi N; Iwai Y; Yamanaka K; Higashiyama S; Takami T; Ohata K
    J Nucl Med; 2008 May; 49(5):694-9. PubMed ID: 18413375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference of 14C turnovers in brain and in transplanted glioma after intravenous injection of 14C-1-pyruvate into rats.
    Hara T; Yokoi F
    Eur J Nucl Med; 1986; 12(5-6):249-51. PubMed ID: 3490980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET: brain tumor biochemistry.
    Roelcke U
    J Neurooncol; 1994; 22(3):275-9. PubMed ID: 7760107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of 11C-labelled BCNU and SarCNU in gliomas studied by PET.
    Mitsuki S; Diksic M; Conway T; Yamamoto YL; Villemure JG; Feindel W
    J Neurooncol; 1991 Feb; 10(1):47-55. PubMed ID: 1902507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of PET studies in brain tumors.
    Herholz K; Wienhard K; Heiss WD
    Cerebrovasc Brain Metab Rev; 1990; 2(3):240-65. PubMed ID: 2121212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular imaging of epidermal growth factor receptor in glioma-bearing rats].
    Wang H; Yu JM; Song XR; Yang GR; Mu DB; Zhao SQ; Wang XW; Wei L; Liu YL; Song B; Fu Z; Teng XP
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):343-6. PubMed ID: 18953832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biodistribution of no-carrier-added [1-11C]putrescine.
    McPherson DW; Fowler JS; Wolf AP; Arnett CD; Brodie JD; Volkow N
    J Nucl Med; 1985 Oct; 26(10):1186-9. PubMed ID: 3876415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Positron emission tomographic evaluations on hemodynamics and glucose metabolism of brain tumors and perifocal edematous tissues].
    Mizukawa N; Hino A; Imahori Y; Tenjin H; Yano I; Yoshino E; Hirakawa K; Yamashita M; Oki F; Nakahashi H
    No To Shinkei; 1989 Mar; 41(3):251-8. PubMed ID: 2787998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.